Scientists find potential new drug target to prevent Ebola
The finding, published in the journal PLOS Biology, not only deepens our understanding of how the virus works, but also offers a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Drugs
AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase
The deal is AstraZeneca's second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare…
Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline
The 12 blockbuster drugs include nine medicines and vaccines with 2 billion to 5 euros ($2.15-$5.38 billion) in peak sales…
IPC issues alert against adverse reactions of painkiller Meftal
The commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of…
Pfizer to price COVID treatment Paxlovid at $1,390 per course
Paxlovid, the most commonly prescribed at home treatment for COVID19 in the U.S., will remain available for free to patients there…
Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets
This product will be manufactured at Lupin’s Somerset facility in the U.S.
Enzene Biosciences launches Bevacizumab
Manufactured using Enzene Biosciences’ patented Continuous Manufacturing Process, Bevacizumab is a biosimilar to Avastin and will…
Prices of 103 formulation packs to come down after NPPA cap
The new prices will be effective from today, NPPA said in a notification on its website
DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?
Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma…
NPPA seeks to recover Rs 4,551 crore for overcharging
82 per cent of the total amount is under litigation